OBJECTIVE To assess the efficacy and complications of device occlusion of atrial septal
defects in adults, using the Amplatzer septal occluder (ASO). DESIGN A prospective …

We are reporting the worldwide experience in closing atrial septal defects (ASDs) in children
and adults using the Amplatzer Septal Occluder (ASO) as of July 2000. The outcome …

The Amplatzer septal occluder (ASO) is used for transcatheter closure of atrial septal defects
(ASDs). This study aimed to determine the factors influencing successful closure with the …

Little is known about the efficacy and safety of the 40 mm Amplatzer septal occluder (ASO).
Thirty‐three patients (22 female, 11 male) with a large secundum atrial septal defect (ASD) …

We reviewed our experience using the Amplatzer septal occluder (AGA Medical, Golden
Valley, MN, USA) to close large, secundum-type atrial septal defects (ASDs) in children …

Objectives We sought to assess the safety and efficacy of percutaneous closure of atrial
septal defects (ASDs) under fluoroscopic guidance only, without periprocedural …

Our study reports the results of a comparison of closure of atrial septal defect (ASD)
surgically with transcatheter closure using the Amplatzer septal occluder. Patients having an …

Background: From January, 1997, as part of an international multicentric trial, we have been
closing small-to-moderate atrial septal defects within the oval fossa using the Amplatzer …

Aims: To analyze the efficacy and follow‐up results of percutaneous closure of Atrial septal
defect (ASD) with the Amplatzer® septal occluder in children aged< 10 years old. Methods …

Transcatheter closure of atrial septal defects (ASDs) was performed mainly in children and
adolescents. Information about outcome and complications in adults was limited. From …